Select for export Effects of psychedelic use on authoritarian attitudes revisited Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811261443677 PubMed 42068187 Copy citation Copy BibTeX Journal of Psychopharmacology 2026-04-30 Otto Simonsson, Taylor Lyons, Joseph Marks, Hannes Kettner, Leor Roseman, Eline Haijen OpenAlex Published psilocybin DepressionObservational StudyHealthy Volunteers Clinical Trial More
Select for export Psychedelics and the ‘inner healer’: Myth or mechanism? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811241239206 PubMed 38605658 Copy citation Copy BibTeX Journal of Psychopharmacology 2024-04-11 Joseph Peill, M. Marguilho, David Erritzøe, Tommaso Barba, Kyle T. Greenway, Fernando E. Rosas OpenAlex Published psilocybin DepressionChronic PainMechanism of Action Randomized Controlled Trial More
Select for export Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811241237870 PubMed 38520045 Copy citation Copy BibTeX Journal of Psychopharmacology 2024-03-21 David Erritzøe, Tommaso Barba, Meg J. Spriggs, Fernando E. Rosas, David Nutt, Robin Carhart-Harris OpenAlex Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
Select for export A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811231167848 PubMed 37122239 Copy citation Copy BibTeX Journal of Psychopharmacology 2023-04-24 Brandon Weiss, David Erritzøe, Bruna Giribaldi, David Nutt, Robin Carhart-Harris OpenAlex Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
Select for export Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221146356 PubMed 36601974 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-12-31 Matthias Forstmann, Hannes Kettner, Christina Sagioglou, Alexander Irvine, Sam Gandy, Robin Carhart-Harris OpenAlex Published psilocybin AddictionPharmacologyToxicity Other More
Select for export Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221125354 PubMed 36433778 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-11-25 Shukuroglou M, Roseman L, Wall M, Nutt D, Kaelen M, Carhart-Harris R. Europe PMC Published psilocybin DepressionBrain ImagingMechanism of Action Other More
Select for export Body mass index (BMI) does not predict responses to psilocybin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221131994 PubMed 36373934 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-11-13 Spriggs MJ, Giribaldi B, Lyons T, Rosas FE, Kärtner LS, Buchborn T Europe PMC Published psilocybin Receptor PharmacologyWellbeingEmotional Processing Other More
Select for export Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881119895520 PubMed 31941394 Copy citation Copy BibTeX Journal of Psychopharmacology 2020-01-15 Lea J. Mertens, Matthew B. Wall, Leor Roseman, Lysia Demetriou, David Nutt, Robin Carhart-Harris OpenAlex Published psilocybin DepressionChronic PainBrain Imaging Other More
Select for export Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881117748902 PubMed 29338538 Copy citation Copy BibTeX Journal of Psychopharmacology 2018-01-16 Lyons T, Carhart-Harris RL. Europe PMC Published psilocybin DepressionPersonality ChangeObservational Study Observational Study More
Select for export Psychiatry's next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881113494107 PubMed 23784738 Copy citation Copy BibTeX Journal of Psychopharmacology 2013-06-18 Carhart-Harris RL, Brugger S, Nutt DJ, Stone JM. Europe PMC Published psilocybin Depression Other More
Select for export The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary investigation of tolerability. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881110367445 PubMed 20395317 Copy citation Copy BibTeX Journal of Psychopharmacology 2010-04-14 Carhart-Harris RL, Williams TM, Sessa B, Tyacke RJ, Rich AS, Feilding A Europe PMC Published psilocybin Brain ImagingAgingSafety Other More
Psilocybin-Research.com
Searchable psilocybin and psilocin bibliometric database.